JE Henningfield, DK Hatsukami, M Zeller… - Drug and Alcohol …, 2011 - Elsevier The rate of initiation and progression to dependence and premature mortality are higher for tobacco products than for any other dependence producing substance. This is not explained simply by the addictiveness (“abuse liability”) or by enticing product designs (“product appeal”) ... Related articles - All 3 versions
LA Zawertailo - Human Psychopharmacology: Clinical and …, 2011 - Wiley Online Library ... Letter to the Editor. Author's response to Miller, SC: Dextromethorphan to dextrorphan: a pathway towards abuseliability. LA Zawertailo. ... How to Cite. Zawertailo, LA (2011), Author's response to Miller, SC: Dextromethorphan to dextrorphan: a pathway towards abuseliability. ...
ML Banks, PG Roma, JE Folk, KC Rice… - Psychopharmacology, 2011 - Springer Abstract Rationale Delta-opioid agonists enhance the antinocicep- tive efficacy of methadone and other mu-opioid agonists. However, relatively little is known about the degree to which delta agonists might enhance the abuse-related effects of mu agonists. Objective This study ... Related articles - All 2 versions
MB Gatch, MJ Forster, A Janowsky… - Journal of Pharmacology …, 2011 - ASPET The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-α-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and ... Related articles - All 2 versions
SC Miller - Human Psychopharmacology: Clinical and …, 2011 - Wiley Online Library ... Letter to the Editor. Dextromethorphan to dextrorphan: a pathway towards abuseliability †. Shannon C. Miller 1,2. ... Additional Information. How to Cite. Miller, SC (2011), Dextromethorphan to dextrorphan: a pathway towards abuseliability. ...